Utilizes proprietary microfluidic platforms to automate the non-viral delivery of gene-editing molecules into human cells.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CellFE develops a microfluidics-based cell engineering platform designed to optimize the manufacturing and development of advanced cellular therapies. The system utilizes rapid mechanical deformations and compressions within compact benchtop devices to transport diverse gene-editing molecules and large payloads into target cells without requiring viral vectors or electroporation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CellFE Management Team
Investors
Cota Capital
Dynamk Capital
Elm Ventures
Embark Ventures
McEwan Lane Family Trust
CellFE Valuations & Financials
View real-time NPM data on CellFE stock including daily CellFE stock price estimates, valuation history, and historical share price information. Access CellFE financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CellFE pricing across six independent market signals. Looking for private company due diligence data sources on CellFE? Get in touch to learn more.
Similar Companies
like CellFE
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Youverify
Cybersecurity
Provides compliance automation to mitigate fraud, ensure regulatory compliance, and streamline customer onboarding.
GaiaNet
Enables scalable deployment and management of open-source LLMs with customizable knowledge bases via a decentralized AI ecosystem.
Ocient
Enterprise Software
Offers a hyperscale data warehouse designed for real-time analysis of large-scale, complex datasets.
Payactiv
Delivers on-demand earned wage access and digital budgeting tools to eliminate cash flow stress for hourly workforces.
Fastino
AI & Machine Learning
Develops high-performance, task-optimized language models (TLMs) designed for enterprise AI developers.
Shadowfax AI
Delivers tech‑driven last‑mile and express delivery services with intelligent routing and automated fulfillment solutions.
Plenful
Healthcare & Life Sciences
Streamlines administrative workflows, enhancing efficiency and compliance in pharmacy operations.
Oak Essentials
Manufactures clean skincare products and botanical beauty treatments using sustainable ingredients.
FAQ
We have answers
CellFE stock does not trade on public stock exchanges. CellFE stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CellFE stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CellFE Stock does not trade on public stock exchanges. In order to sell CellFE shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CellFE does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CellFE share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CellFE stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CellFE stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CellFE stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CellFE is a private company and has not had an IPO. There is currently no CellFE IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CellFE IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
